Arena pharmaceuticals, inc. (ARNA)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Operating Activities:
Net income (loss)

397,555

-29,399

-92,732

-22,896

-107,979

-60,508

-19,435

-85,477

-109,224

-124,534

-153,204

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
(Income) loss from discontinued operations

-

-830

3,122

-10,596

2,728

-

-

-

-

-

-

Depreciation and amortization

3,233

3,759

4,278

4,994

5,430

8,655

7,733

9,055

10,127

10,393

11,018

Deferred income taxes

110,333

-110,333

-

-

-

-

-

-

-

-

-627

Non-cash collaboration revenue

-

1,500

-

-

-

-

-

-

-

-

-

Non-cash royalty revenue

-3,744

3,315

-

-

-

-

-

-

-

-

-

Amortization of intangibles

-

-

-

-

-

506

469

691

997

2,159

3,508

Share-based compensation

53,047

19,543

7,855

11,075

14,112

13,509

9,024

5,072

3,748

5,495

7,149

Gain from valuation of derivative liabilities

-

-

-

-

474

4,418

10,150

-13,425

47

4,371

5,418

Litigation settlement expense, net

-

-

11,975

-

-

-

-

-

-

-

-

Gain on sale of available-for-sale securities

-

-

-

-

-

49,553

0

0

-

-

-

Amortization of short-term investment premium

-

-

-

-

-

-

-

-

-

-

69

Amortization of prepaid financing costs

90

110

136

136

136

136

136

292

438

545

338

Amortization of original issue discounts, net of premiums, on available-for-sale investments

5,628

664

-

-

-

-

-

-

-

-

-

Investment write-down

-

-

-

-

-

-

-

-

1,963

0

0

Loss on extinguishment of debt

-

-

-

-

-

-

-

-6,338

-10,514

-12,354

-2,479

Loss (gain) on disposal of property and equipment

-112

791

379

-1,270

-1,007

-172

-49

31

-18

14

-313

Changes in operating assets and liabilities:
Accounts receivable

-3,432

2,760

-10,787

12,246

-781

-6,407

4,473

5,260

-2,878

1,931

-430

Inventory

-

-

-

-

-

-870

6,065

5,875

0

0

-

Prepaid expenses and other assets

8,133

2,929

-585

-2,416

641

772

65

1,524

-539

-1,608

929

Payables and accrued liabilities

12,347

10,871

1,803

2,410

-2,092

13,240

19,572

276

-1,117

-5,644

-28,765

Accrued litigation settlement

-

-11,975

-

-

-

-

-

-

-

-

-

Deferred revenues

-1,438

-2,061

-4,401

-69,078

-4,647

-29,764

75,880

17,849

-3,395

43,991

37

Deferred rent

-

-

-

-

-

122

125

-103

-187

-152

-129

Other long-term liabilities

-

-1,265

-577

30

101

-

-

-

-

-

-

Net cash provided by (used in) operating activities - continuing operations

568,694

-131,879

-63,792

-71,293

-96,994

-101,398

-

-44,047

-

-

-

Net cash used in operating activities - discontinued operations

-

-333

-2,850

9,817

-1,119

-

-

-

-

-

-

Net cash provided by (used in) operating activities

568,694

-132,212

-66,642

-61,476

-98,113

-

72,800

-

-78,257

-52,315

-155,925

Investing Activities:
Proceeds from sale of available-for-sale securities

-

-

-

-

-

49,553

0

0

-

-

-

Purchases of available-for-sale investments

1,469,220

364,539

112,615

-

-

-

-

-

-

1,231

20,433

Proceeds from sale and maturity of available-for-sale investments

976,093

110,564

-

-

-

-

-

-

-

-

-

Deconsolidation of variable interest entity

-

-

406

-

-

-

-

-

-

-

-

Proceeds from sales/maturities of short-term investments, available-for-sale

-

-

-

-

-

-

-

-

-

21,664

36,696

Purchases of property and equipment

4,819

692

113

814

1,119

8,905

9,164

1,777

619

4,211

5,331

Proceeds from sale of property and equipment

-

-

789

954

2,232

47

60

31

33

47

-

Proceeds from sale of equipment

-

-

-

-

-

-

-

-

-

-

263

Other non-current assets

-

11

5

654

-609

-209

-439

425

86

-48

-170

Net cash used in investing activities - continuing operations

-497,946

-254,678

-112,350

-514

1,722

40,904

-

-2,171

-

-

-

Net cash provided by (used in) investing activities - discontinued operations

997

3,405

-40

-236

-9,873

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-496,949

-251,273

-112,390

-750

-8,151

-

-8,665

-

-672

16,317

11,365

Financing Activities:
Proceeds from issuance of note payable and related financial instruments to Deerfield

-

-

-

-

-

-

-

-

-

-

96,865

Proceeds from lease financing

-

-

-

-

-

-

-

-

-

-

15,000

Principal payments on lease financing obligations

3,282

4,000

3,518

2,979

2,492

2,057

1,664

1,313

998

717

581

Proceeds from issuance of common stock, net

13,147

389,031

248,805

370

103,628

5,225

3,315

151,218

17,977

120,466

65,368

Other financing activities

-

-

-

320

-

-

-

-

-

-

-

Proceeds from issuance of preferred stock

-

-

-

-

-

-

-

16,462

17,662

0

0

Net cash provided by (used in) financing activities

-

-

-

-

-

3,168

-

144,106

-

-

-

Net cash provided by financing activities

9,865

385,031

245,287

-2,289

101,136

-

1,651

-

-14,158

89,749

166,652

Effect of exchange rate changes on cash

-10

654

1,870

-294

-1,897

-1,343

1

571

50

2,185

-688

Net increase (decrease) in cash, cash equivalents and restricted cash

81,600

2,200

68,125

-64,809

-7,025

-58,669

65,787

98,459

-93,037

55,936

21,404

Supplemental disclosure of cash flow information:
Interest paid

4,787

5,696

5,967

6,303

6,562

6,778

6,954

7,670

9,492

13,434

10,297

Supplemental disclosure of non-cash investing and financing information:
Disposition of property and land upon lease expiration

-

3,944

-

-

-

-

-

-

-

-

-

Reduction in lease financing obligation from release of residual value upon lease expiration

-

5,039

-

-

-

-

-

-

-

-

-

Conversion of preferred stock into common stock

-

-

-

-

-

-

-

14,561

15,413

0

0

Deemed dividend related to beneficial conversion feature of convertible preferred stock

-

-

-

-

-

-

-

2,824

2,260

0

0

Retirement of treasury stock

-

-

-

-

-

-

-

23,070

0

0

-

Payable to Siegfried for acquisition of land and building

-

-

-

-

-

-

-

110

46

12

79